Generalized dystrophic epidermolysis bullosa: identification of a novel, homozygous glycine substitution, G2031S, in exon 73 of COL7A1 in monozygous triplets
E.J. Nordal
Departments of Dermatology and Paediatrics, Ullevål Hospital and University of Oslo, Oslo, Norway
Search for more papers by this authorS. Mecklenbeck
Department of Dermatology, University of Münster, Münster, Germany
Search for more papers by this authorI. Hausser
Electron Microscopic Laboratory, Department of Dermatology and Venereology, University of Heidelberg, Heidelberg, Germany
Search for more papers by this authorJ. Skranes
Departments of Dermatology and Paediatrics, Ullevål Hospital and University of Oslo, Oslo, Norway
Search for more papers by this authorL. Bruckner-Tuderman
Department of Dermatology, University of Münster, Münster, Germany
Search for more papers by this authorT. Gedde-Dahl Jr
Institute of Forensic Medicine and Dermatological DNA Laboratory, Department of Dermatology, Rikshospitalet and University of Oslo, Oslo, Norway
Search for more papers by this authorE.J. Nordal
Departments of Dermatology and Paediatrics, Ullevål Hospital and University of Oslo, Oslo, Norway
Search for more papers by this authorS. Mecklenbeck
Department of Dermatology, University of Münster, Münster, Germany
Search for more papers by this authorI. Hausser
Electron Microscopic Laboratory, Department of Dermatology and Venereology, University of Heidelberg, Heidelberg, Germany
Search for more papers by this authorJ. Skranes
Departments of Dermatology and Paediatrics, Ullevål Hospital and University of Oslo, Oslo, Norway
Search for more papers by this authorL. Bruckner-Tuderman
Department of Dermatology, University of Münster, Münster, Germany
Search for more papers by this authorT. Gedde-Dahl Jr
Institute of Forensic Medicine and Dermatological DNA Laboratory, Department of Dermatology, Rikshospitalet and University of Oslo, Oslo, Norway
Search for more papers by this authorAbstract
We report monozygous triplets affected with dystrophic epidermolysis bullosa (DEB). The female triplets were delivered by Caesarean section and skin fragility of each child, which was partly induced by trauma, was apparent from the third to fourth day of life. Clinically, the triplets were equally affected. Mutation analysis in this family revealed a novel recessively expressed glycine substitution, G2031S, in exon 73 of the collagen VII gene COL7A1. Most glycine substitutions in this gene region encoding for the triple helical domain of collagen VII are associated with milder, dominantly inherited phenotypes. By contrast, the novel point mutation of this study is clinically silent in the heterozygous state and leads to a severe DEB subtype when homozygous.
References
- 1 Burgeson RE. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 1993; 101: 252 – 5.
- 2 Gedde-Dahl T Jr & Anton-Lamprecht I. Epidermolysis bullosa. In: Emery and Rimoin’s Principles and Practice of Medical Genetics( DL Rimoin, JM Connor, RE Pyeritz, eds), 3rd edn, Vol. 1. New York: Churchill Livingstone, 1996: 1225 – 78.
- 3 Bruckner-Tuderman L. Hereditary skin diseases of anchoring fibrils. J Dermatol Sci 1999; 20: 122 – 33.DOI: 10.1016/s0923-1811(99)00018-3
- 4 Whittock NV, Ashton GHS & Mohammedi R et al. Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage of mismatch, and conformation sensitive gel electrophoresis. J Invest Dermatol 1999; 113: 673 – 86.DOI: 10.1046/j.1523-1747.1999.00732.x
- 5 Christiano AM, McGrath JA, Tan KC & Uitto J. Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance. Am J Hum Genet 1996; 58: 671 – 81.
- 6
Järvikallio A,
Pulkkinen L &
Uitto J.
Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1).
Hum Mutat
1997; 10: 338
–
47.
10.1002/(SICI)1098-1004(1997)10:5<338::AID-HUMU2>3.0.CO;2-B CAS PubMed Web of Science® Google Scholar
- 7 Uitto J, Pulkkinen L & Christiano AM. The molecular basis of the dystrophic forms of epidermolysis bullosa. In: Epidermolysis Bullosa Clinical, Epidemiological, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry( J-D Fine, EA Bauer, J McGuire, A Moshell, eds). Baltimore: Johns Hopkins University Press, 1999: 326 – 50.
- 8 Christiano AM, Chung-Honet LC, Hovnanian A & Uitto J. PCR-based detection of two exonic polymorphisms in the human type VII collagen gene (COL7A1) at 3p21.1 Genomics 1992; 14: 827 – 8.
- 9 Anton-Lamprecht I. The skin. In: Diagnostic Ultrastructure of Non-neoplastic Diseases( JM Papadimitriou, DW Henderson, DV Spagnolo, eds). Edinburgh: Churchill Livingstone, 1992: 459 – 550.
- 10 Hintner H, Stingl G & Schuler G et al. Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases. J Invest Dermatol 1981; 76: 113 – 18.
- 11 Bruckner-Tuderman L, Höpfner B & Hammami-Hauasli N. Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol 1999; 18: 43 – 54.DOI: 10.1016/s0945-053x(98)00007-9
- 12 Bruckner-Tuderman L, Nilssen Ö & Zimmermann DR et al. Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC2-domain. J Cell Biol 1995; 131: 551 – 9.
- 13 Gayraud B, Höpfner B & Jassim A et al. Characterization of a 50-kDa component of the epithelial basement membrane using a GDA-J/F3 monoclonal antibody. J Biol Chem 1997; 272: 9531 – 8.
- 14 Ganguly A, Rock M & Prockop DJ. Conformation sensitive gel electrophoresis for rapid detection of single-base differences in double strand PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993; 90: 10325 – 9.
- 15 Heagerty AHM, Kennedy AR & Leigh IM et al. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH7:2 monoclonal antibody: use in diagnosis. Br J Dermatol 1986; 115: 125 – 31.
- 16 Shimizu H, McGrath JA & Christiano AM et al. Molecular basis of recessive dystrophic epidermolysis bullosa: genotype/phenotype correlation in a case of moderate clinical severity. J Invest Dermatol 1996; 106: 119 – 24.
- 17 Christiano AM, Greenspan DS & Hoffman GG et al. A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nature Genet 1993; 4: 62 – 6.
- 18 Hilal L, Rochat A & Duquesnoy P et al. A homozygous insertion-deletion in the type VII collagen gene (COL7A1) in Hallopeau-Siemens dystrophic epidermolysis bullosa. Nature Genet 1993; 5: 287 – 93.
- 19 Christiano AM, Anhalt G & Gibbons S et al. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics 1994; 21: 160 – 8.DOI: 10.1006/geno.1994.1238
- 20 Hovnanian A, Hilal L & Blanchet-Bardon C et al. Recurrent nonsense mutations within the type VII collagen gene in patients with severe recessive dystrophic epidermolysis bullosa. Am J Hum Genet 1994; 55: 289 – 96.
- 21 Dunnill MGS, Richards AJ & Milana G et al. A novel homozygous point mutation in the collagen VII gene (COL7A1) in two cousins with recessive dystrophic epidermolysis bullosa. Hum Mol Genet 1994; 3: 1693 – 4.
- 22 Mellerio JE, Dunnill MGS & Allison W et al. Recurrent mutations in the type VII collagen gene (COL7A1) in patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1997; 109: 246 – 9.
- 23 Christiano AM, Ryynänen M & Uitto J. Dominant dystrophic epidermolysis bullosa: identification of a Gly-Ser substitution in the triple-helical domain of type VII collagen. Proc Natl Acad Sci USA 1994; 91: 3549 – 53.
- 24 Winberg J-O, Hammami-Hauasli N & Nilssen Ø et al. Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with different missense mutations in the COL7A1 gene. Hum Mol Genet 1997; 6: 1125 – 35.DOI: 10.1093/hmg/6.7.1125
- 25 Mecklenbeck S, Hammami-Hauasli N & Höpfner B et al. Clustering of COL7A1 mutations in exon 73: implications for mutation analysis in dystrophic epidermolysis bullosa. J Invest Dermatol 1999; 112: 398 – 400.DOI: 10.1046/j.1523-1747.1999.00518.x
- 26 Kon A, Nomura K & Pulkkinen L et al. Novel glycine substitution mutations in COL7A1 reveal that the Pasini and the Cockayne-Touraine variants of dominant dystrophic epidermolysis bullosa are allelic. J Invest Dermatol 1997; 109: 684 – 7.
- 27 Mellerio JE, Salas-Alanis JC & Talamantes ML et al. A recurrent glycine substitution mutation, G2043R, in the type VII collagen gene (COL7A1) in dominant dystrophic epidermolysis bullosa. Br J Dermatol 1998; 139: 730 – 7.
- 28 Cserhalmi-Friedman PB, Karpati S, Horvath A & Christiano AM. Identification of a glycine substitution and a splice site mutation in the type VII collagen gene in a proband with mitis recessive dystrophic epidermolysis bullosa. Arch Dermatol Res 1997; 289: 640 – 5.DOI: 10.1007/s004030050253
- 29 Hovnanian A, Rochat A & Bodemer C et al. Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation. Am J Hum Genet 1997; 61: 599 – 610.
- 30 Christiano AM, McGrath JA & Uitto J. Influence of the second COL7A1 mutation in determining the phenotypic severity of recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1996; 106: 766 – 70.
- 31 Terracina M, Posteraro P & Schubert M et al. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa. J Invest Dermatol 1998; 111: 744 – 50.DOI: 10.1046/j.1523-1747.1998.00397.x
- 32 Shimizu H, Hammami-Hauasli N & Hatta N et al. Compound heterozygosity for silent and dominant glycine substitution mutations in COL7A1 leads to a marked transient intracytoplasmic retention of procollagen VII and a moderately severe dystrophic epidermolysis bullosa phenotype. J Invest Dermatol 1999; 113: 419 – 21.DOI: 10.1046/j.1523-1747.1999.00713.x
- 33 Masunaga T, Shimizu H & Takizawa Y et al. Combination of novel premature termination codon and glycine substitution mutations in COL7A1 leads to moderately severe recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2000; 114: 204 – 5.DOI: 10.1046/j.1523-1747.2000.00848.x
- 34 Kon A, Pulkkinen L & Ishida-Yamamoto A et al. Novel COL7A1 mutations in dystrophic forms of epidermolysis bullosa. J Invest Dermatol 1998; 111: 534 – 7.